Nucleotide-binding oligomerization domain containing 1 (NOD1) haplotypes and single nucleotide polymorphisms modify susceptibility to inflammatory bowel diseases in a New Zealand caucasian population: A case-control study

BMC Research Notes

Volumn 2, Issue , 2009, Pages

  Huebner, Claudia ^a,f   Ferguson, Lynnette R ^a,f   Han, Dug Yeo ^a,f   Philpott, Martin ^a,f   Barclay, Murray L ^b,c   Gearry, Richard B ^b,c   McCulloch, Alan ^d,f   Demmers, Pieter S ^e,f   Browning, Brian L ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b CHRISTCHURCH HOSPITAL   (New Zealand)

^c UNIVERSITY OF OTAGO   (New Zealand)

^d THE NEW ZEALAND INSTITUTE FOR PLANT AND FOOD RESEARCH LIMITED   (New Zealand)

^e INVERMAY AGRICULTURAL CENTRE   (New Zealand)

^f Nutrigenomics New Zealand   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 70449702768     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-2-52     Document Type: Article

References (28)

1. Caspase recruitment domain-containing sensors and adaptors in intestinal innate immunity. P Hruz L Eckmann, Curr 2008 24 2 108 114
2. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. [see comment]. Y Ogura DK Bonen N Inohara DL Nicolae FF Chen R Ramos H Britton T Moran R Karaliuskas RH Duerr, et al. Nature 2001 411 6837 603 606 10.1038/35079114 11385577
3. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. [see comment]. JP Hugot M Chamaillard H Zouali S Lesage JP Cezard J Belaiche S Almer C Tysk CA O'Morain M Gassull, et al. Nature 2001 411 6837 599 603 10.1038/35079107 11385576
4. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. JC Barrett S Hansoul DL Nicolae JH Cho RH Duerr JD Rioux SR Brant MS Silverberg KD Taylor MM Barmada, et al. Nat Genet 2008 40 8 955 962 10.1038/ng.175 18587394
5. CARD4/NOD1 is not involved in inflammatory bowel disease. H Zouali S Lesage F Merlin JP Cezard JF Colombel J Belaiche S Almer C Tysk C O'Morain M Gassull, et al. Gut 2003 52 1 71 74 12477763 10.1136/gut.52.1.71 (Pubitemid 36020768)
6. Association between a complex insertion/deletion polymorphism in NOD1 (CARD4) and susceptibility to inflammatory bowel disease. DP McGovern P Hysi T Ahmad DA van Heel MF Moffatt A Carey WO Cookson DP Jewell, Hum Mol Genet 2005 14 10 1245 1250 10.1093/hmg/ddi135 15790594
7. Influence of a nucleotide oligomerization domain 1 (NOD1) polymorphism and NOD2 mutant alleles on Crohn's disease phenotype. E Canto E Ricart D Busquets D Monfort E Garcia-Planella D Gonzalez J Balanzo JL Rodriguez-Sanchez S Vidal, World J Gastroenterol 2007 13 41 5446 5453 17907287
8. No association between the functional CARD4 insertion/deletion polymorphism and inflammatory bowel diseases in the German population. A Franke A Ruether N Wedemeyer TH Karlsen A Nebel S Schreiber, Gut 2006 55 11 1679 1680 10.1136/gut.2006.104646 17047129
9. Complex insertion/deletion polymorphism in NOD1 (CARD4) is not associated with inflammatory bowel disease susceptibility in East Anglia panel. M Tremelling L Hancock F Bredin D Sharpstone SA Bingham M Parkes, Inflamm Bowel Dis 2006 12 10 967 971 10.1097/01.mib.0000234131.89971.e5 17012967
10. Investigation of NOD1/CARD4 variation in inflammatory bowel disease using a haplotype-tagging strategy. J Van Limbergen ER Nimmo RK Russell HE Drummond L Smith NH Anderson G Davies ID Arnott DC Wilson J Satsangi, Hum Mol Genet 2007 16 18 2175 2186 10.1093/hmg/ddm169 17613538
11. Effect of inflammatory bowel disease classification changes on NOD2 genotype-phenotype associations in a population-based cohort. RB Gearry RL Roberts MJ Burt CM Frampton BA Chapman JA Collett P Shirley MD Allington MA Kennedy ML Barclay, Inflamm Bowel Dis 2007 13 10 1220 1227 10.1002/ibd.20190 17538984
12. Association of DLG5 variants with inflammatory bowel disease in the New Zealand Caucasian population and meta-analysis of the DLG5 R30Q variant. BL Browning C Huebner I Petermann P Demmers A McCulloch RB Gearry ML Barclay AN Shelling LR Ferguson, Inflamm Bowel Dis 2007 13 9 1069 1076 10.1002/ibd.20157 17455201
13. Has toll-like receptor 4 been prematurely dismissed as an inflammatory bowel disease gene? Association study combined with meta-analysis shows strong evidence for association. BL Browning C Huebner I Petermann RB Gearry ML Barclay AN Shelling LR Ferguson, Am J Gastroenterol 2007 102 11 2504 2512 10.1111/j.1572-0241.2007.01463.x 17850411
14. Invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn's disease. J Boudeau AL Glasser E Masseret B Joly A Darfeuille-Michaud, Infect Immun 1999 67 9 4499 4509 10456892
15. NOD2/CARD15, NOD1/CARD4, and ICAM-1 gene polymorphisms in Turkish patients with inflammatory bowel disease. SC Ozen U Dagli MY Kilic M Toruner Y Celik M Ozkan I Soykan H Cetinkaya A Ulker A Ozden, et al. J Gastroenterol 2006 41 4 304 310 10.1007/s00535-005-1780-z 16741608
16. NOD1 gene E266K polymorphism is associated with disease susceptibility but not with disease phenotype or NOD2/CARD15 in Hungarian patients with Crohn's disease. T Molnar P Hofner F Nagy PL Lakatos S Fischer L Lakatos A Kovacs I Altorjay M Papp K Palatka, et al. Dig Liver Dis 2007 39 12 1064 1070 10.1016/j.dld.2007.09.003 17964870
17. Contribution of the NOD1/CARD4 insertion/deletion polymorphism +32656 to inflammatory bowel disease in Northern Europe. J Van Limbergen RK Russell ER Nimmo L Torkvist CW Lees HE Drummond L Smith NH Anderson PM Gillett P McGrogan, et al. Inflamm Bowel Dis 2007 13 7 882 889 10.1002/ibd.20124 17285593
18. NOD1 variation, immunoglobulin E and asthma. P Hysi M Kabesch MF Moffatt M Schedel D Carr Y Zhang B Boardman E von Mutius SK Weiland W Leupold, et al. Hum Mol Genet 2005 14 7 935 941 10.1093/hmg/ddi087 15718249
19. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. A Darfeuille-Michaud J Boudeau P Bulois C Neut AL Glasser N Barnich MA Bringer A Swidsinski L Beaugerie JF Colombel, Gastroenterology 2004 127 2 412 421 10.1053/j.gastro.2004.04.061 15300573
20. High incidence of Crohn's disease in Canterbury, New Zealand: results of an epidemiologic study. RB Gearry A Richardson CM Frampton JA Collett MJ Burt BA Chapman ML Barclay, Inflamm Bowel Dis 2006 12 10 936 943 10.1097/01.mib. 0000231572.88806.b9 17012964
21. The significance of haemochromatosis gene mutations in the general population: implications for screening. MJ Burt PM George JD Upton JA Collett CM Frampton TM Chapman TA Walmsley BA Chapman, Gut 1998 43 6 830 836 9824612
22. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. MS Silverberg J Satsangi T Ahmad ID Arnott CN Bernstein SR Brant R Caprilli JF Colombel C Gasche K Geboes, et al. Can J Gastroenterol 2005 19 Suppl A 5 36 16151544
23. Automated mass spectrometry: a revolutionary technology for clinical diagnostics. J Leushner NH Chiu, Mol Diagn 2000 5 4 341 348 11172498
24. High-throughput multiplex SNP genotyping with MALDI-TOF mass spectrometry: practice, problems and promise. MS Bray E Boerwinkle PA Doris, Hum Mutat 2001 17 4 296 304 10.1002/humu.27 11295828
25. From genotypes to genes: doubling the sample size. PD Sasieni, Biometrics 1997 53 4 1253 1261 10.2307/2533494 9423247
26. A note on exact tests of Hardy-Weinberg equilibrium. JE Wigginton DJ Cutler GR Abecasis, Am J Hum Genet 2005 76 5 887 893 15789306 10.1086/429864 (Pubitemid 40563110)
27. R: A language for data analysis and graphics. R Ihaka R Gentleman, Journal of Computational and Graphical Statistics 1996 5 3 299 314 10.2307/1390807
28. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. YY Shi L He, Cell Res 2005 15 2 97 98 10.1038/sj.cr.7290272 15740637